title: When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies.
authors.forename: Andrew N
authors.initials: AN
authors.lastname: Phillips
authors.forename: Alessandro Cozzi
authors.initials: AC
authors.lastname: Lepri
authors.forename: Fiona
authors.initials: F
authors.lastname: Lampe
authors.forename: Margaret
authors.initials: M
authors.lastname: Johnson
authors.forename: Caroline A
authors.initials: CA
authors.lastname: Sabin
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D018570:Risk Assessment
chemical_list: D019380:Anti-HIV Agents